Literature DB >> 1501423

Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction.

A Soupart1, R Penninckx, A Stenuit, O Perier, G Decaux.   

Abstract

The role of the rate of correction in the development of demyelinating brain lesions after correction of chronic severe hyponatremia is controversial. It has been recently suggested in rats treated by intravenous (i.v.) hypertonic saline (NaCl) that both the rate and the absolute change in serum sodium represent critical risk factors. However, we previously demonstrated in rats treated by intraperitoneal (i.p.) injections of NaCl that below a threshold of serum sodium rise of 20 mEq/liter/24 hr, only 5% of the brain lesions were recorded, even in rats submitted to a rapid (1 hr) serum sodium increment following the i.p. injection. Working below this threshold (serum sodium rise less than 20 mEq/liter/24 hr) in the present work, allowed us to independently determine the role of the rate in the outcome of the correction. This was done by submitting the rats to a rapid (1 hr) intravenous infusion of NaCl. As a difference between the i.p. and i.v. route in the degree of volume expansion produced by the NaCl administration could also play a role in the pathogenesis of the brain lesions, rats treated with rapid i.v. infusion of NaCl (associated with volume expansion) were compared to a group of rats treated with water restriction (associated to volume contraction) to evaluate the role of volemia on the incidence of neurological damage. Hyponatremia was induced over three days with d-glucose in water and vasopressin. The group 1 was corrected by intravenous (i.v.) infusion of hypertonic saline over one hour.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501423     DOI: 10.1038/ki.1992.239

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Hyponatremia.

Authors:  Jameela Al-Salman; David Kemp; Daniel Randall
Journal:  West J Med       Date:  2002-05

2.  Minocycline protects against neurologic complications of rapid correction of hyponatremia.

Authors:  Fabrice Gankam-Kengne; Alain Soupart; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

3.  Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations.

Authors:  Casey Dellabarca; Karen S Servilla; Blaine Hart; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 4.  Therapeutic Relowering of Plasma Sodium after Overly Rapid Correction of Hyponatremia: What Is the Evidence?

Authors:  Helbert Rondon-Berrios
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-10       Impact factor: 8.237

5.  100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Metab Brain Dis       Date:  2010-03-11       Impact factor: 3.584

6.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

7.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Authors:  J S Videen; T Michaelis; P Pinto; B D Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

Review 8.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

Review 9.  Hyponatremia and the Brain.

Authors:  Fabrice Gankam Kengne; Guy Decaux
Journal:  Kidney Int Rep       Date:  2017-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.